2014-09-30 16:39:25 UTC

Risk of Esophageal Cancer Decreases With Height

Oct. 2, 2014

Aaron P. Thrift and colleagues report in Clinical Gastroenterology and Hepatology that height is associated inversely with risk of esophageal adenocarcinoma and Barrett's esophagus.

Risks for some cancers increase with height. Aaron P. Thrift and colleagues investigated the relationship between height and risk of esophageal adenocarcinoma and its precursor, Barrett's esophagus. Dr. Thrift comments on the findings, which were published in Clinical Gastroenterology and Hepatology.

“Individuals in the lowest quartile of height (under 5’7” for men and 5’2” for women) were roughly twice as likely as individuals in the highest quartile of height (taller than 6’ for men and 5’5” for women) to have Barrett’s esophagus or esophageal cancer,” said Dr. Thrift, lead study author from the Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA. “Interestingly, the relationship between height and esophageal cancer is opposite from many other cancers — including colorectal, prostate and breast — where greater height is associated with an increased risk.”

Read more about this study in the AGA press release

More on Barrett's Esophagus

Principles of GI for the NP and PA

Aug. 10, 2018

Hear from the experts as they provide you with critical updates on treating and managing patients with a variety of GI disorders.

2018 AGA Postgraduate Course

June 2, 2018

Secure your spot for this clinically focused, multi-topic course that offers immediately applicable information. Held in conjunction with DDW®. Save $75 when you register by April 18.

How to Talk with Your Patients About PPIs and Cognitive Decline

Feb. 22, 2018

More information clearing concerns about the use of proton pump inhibitors (PPIs).